Temporary Peripheral Nerve Stimulation System for Osteoarthritis of the Knee

Description

The purpose of this study is to demonstrate the treatment outcomes of patients with chronic knee pain secondary to osteoarthritis that have received a temporary peripheral nerve stimulation system.

Conditions

Osteoarthritis, Knee, Osteoarthritis

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to demonstrate the treatment outcomes of patients with chronic knee pain secondary to osteoarthritis that have received a temporary peripheral nerve stimulation system.

Efficacy of a Temporary Peripheral Nerve Stimulation System in Patients with Osteoarthritis of the Knee

Temporary Peripheral Nerve Stimulation System for Osteoarthritis of the Knee

Condition
Osteoarthritis, Knee
Intervention / Treatment

-

Contacts and Locations

Fond Du Lac

Aurora Health Center, Fond Du Lac, Wisconsin, United States, 54937

Oshkosh

Aurora Health Oshkosh, Oshkosh, Wisconsin, United States, 54914

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age of 21 and older
  • * Will receive a temporary PNS system for the management of chronic knee pain secondary to osteoarthritis
  • * Be capable of subjective evaluation, able to read and understand English-written questionnaires, and able to read, understand and sign the written informed consent in English
  • * Be willing and capable of giving informed consent
  • * Be willing and able to comply with study-related requirements, procedures, and scheduled visits
  • * No knee pain at rest
  • * Same nerve targeted for both Radiofrequency Ablation (RFA) and Peripheral Nerve Stimulation (PNS) in less than 6 months post RFA, if applicable
  • * Pregnancy
  • * History of repetitive skin infections
  • * Vulnerable populations (e.g., prisoners, minors, students, employees)
  • * Any other condition that may interfere with the ability to participate in a clinical trial (e.g., anatomy that may interfere with lead placement, nerve damage, compromised immune system, uncontrolled diabetes)
  • * Confounding conditions such as lumbar radiculopathy
  • * Deep brain stimulation system, implanted active cardiac implant (e.g. pacemaker of defibrillator), or any other implantable neuro-stimulator whose stimulus current pathway may overlap the SPRINT system.
  • * Be involved in an injury claim under current litigation
  • * Be a recipient of temporary Social Security Disability Insurance (SSDI) benefits due to chronic pain
  • * Have a pending or approved worker's compensation claim

Ages Eligible for Study

21 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Wake Forest University Health Sciences,

Mansoor M Aman, MD, PRINCIPAL_INVESTIGATOR, Director, Interventional Pain Medicine- Oshkosh & Fond du Lac Department of Anesthesiology

Study Record Dates

2025-12-31